Sonex Health
Amy Stegner, MHA, is an experienced healthcare professional with a robust background in clinical affairs and research operations. Currently serving as the Vice President of Clinical Affairs at Sonex Health, Amy has held significant leadership positions at Abbott as Director of Global Clinical Affairs and CVS Health as Head of Quality and Compliance in Clinical Trial Services. Additionally, Amy's roles at NAMSA included Associate Vice President of Clinical Research Services and Director of North America Clinical Research Services and Global Data Management. Previously, Amy was the Director of Research Operations at Allina Health. Academic credentials include a Master's of Healthcare Administration from the University of Minnesota and studies at the University of Minnesota - Carlson School of Management.
This person is not in any offices
Sonex Health
Sonex Health reduces invasiveness, improves safety, and lowers the cost of care through transformative ultrasound.“Refined simplicity” is the guiding principle behind Sonex Health. To drive efforts and innovations that result in elegant, effective solutions to some of the healthcare system’s most pressing needs. Mayo Clinic physicians DarrylBarnes, MD and Jay Smith, MD, and business operations expert Aaron Keenan founded Sonex Health in 2014. Sonex Health has developed the SX-One MicroKnife(R) with Meerkat Technology™ to treat carpal tunnel syndrome in a novel fashion, termed Micro-invasive Carpal Tunnel Release. This innovation allows a procedure that once took place in an operating room to be safely and effectively performed in a surgery center or office setting, resulting in rapid patient recovery, improved cosmesis, and reduced costs.The ultra-low-profile SX-One MicroKnife with Meerkat Technology is an innovative surgical device that enables physicians to perform Micro-invasive Carpal Tunnel Release surgery through a single micro-incision under ultrasound guidance, or with a traditional mini-open incision without ultrasound guidance. The SX-One MicroKnife utilizes a micro-incision that’s up to five times smaller than the incision made during traditional CTR surgery—an incision so small, it can be closed with a small adhesive bandage or strip instead of sutures or stitches. The result is a low-trauma surgical environment that has been associated with a more rapid recovery. Immobilization is unnecessary so patients can begin rehabilitation and get back to their jobs and lives.